A recent study published in NIH found that electronic nicotine delivery systems (ENDS) seem to cause less bronchial epithelial cells toxicity in comparison to cigarettes.
The study confirmed the reduced toxicity of ENDS (electronic nicotine delivery systems) compared to cigarettes.
Titled, “Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to a cigarette: the Replica Project,” the study aimed to replicate three published studies looking and comparing the cytotoxic and inflammatory effects of cigarette smoke and ENDS aerosol, in an independent multi-center ring study.
The research team established the reliability of results and the robustness of conclusions by replicating the authors’ experimental protocols and then also validating via different methods. After human bronchial epithelial cells (NCI-H292) were exposed to cigarette smoke and e-cig vapor, the researchers assessed the inflammatory cytokines interleukin-6 and interleukin-8 and the remodeling mediator matrix metalloproteinase-1.
The researchers confirmed that almost 80% of cytotoxic effects are due to volatile compounds in the vapor phase of smoke. To this effect, they confirmed the reduced cytotoxic effects of ENDS aerosol. However, the data gathered on inflammatory and remodeling activity triggered by smoke differed significantly from those in the original reports. Considering the independent data gathered from multiple laboratories, the study confirmed the reduced toxicity of ENDS compared to cigarettes.
Source: https://www.vapingpost.com/
